Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis.

Jura-Szoltys, Edyta; Gawlik, Radoslaw; Branicka, Olga; Stryjewska-Makuch, Grazyna; Glück, Joanna

Jura-Szoltys, Edyta; Gawlik, Radoslaw; Branicka, Olga; Stryjewska-Makuch, Grazyna; Glück, Joanna.

Afiliação

Jura-Szoltys E; Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.
Gawlik R; Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.
Branicka O; Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.
Stryjewska-Makuch G; Department of Laryngology and Laryngological Oncology, Upper Silesian Medical Centre, Independent Public Research Hospital No. 7 of Silesian Medical University, Katowice, Poland.
Glück J; Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.

Postepy Dermatol Alergol ; 39(6): 1110-1115, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36686010

Palavras-chave

allergen immunotherapy; eosinophil; intermittent allergic rhinitis; nasal cytology; rhinomanometry; total nasal symptom score

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Postepy Dermatol Alergol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google